Biotechnological doxorubicin production: pathway and regulation engineering of strains for enhanced production

Doxorubicin (DXR) is an anthracycline-type polyketide, typically produced by Streptomyces peucetius ATCC 27952. Like the biosynthesis of other secondary metabolites in Streptomyces species, DXR biosynthesis is tightly regulated, and a very low level of DXR production is maintained in the wild-type strain. Despite that DXR is one of the most broadly used and clinically important anticancer drugs, a traditional strain improvement strategy has long been practiced via recursive random mutagenesis, with little understanding of the molecular genetic basis underlying such enhanced DXR production. Since DXR titer enhancement is imperative in the fermentation industry, attaining a comprehensive understanding and its application of the specific regulatory systems that govern secondary metabolite production is an important aspect of metabolic engineering that can efficiently improve fermentation titers. In this mini-review, various efforts to improve the titers of DXR have been summarized based on biosynthetic and regulatory studies including transcriptional and product analyses.

[1]  C. Hutchinson,et al.  Regulation of daunorubicin production in Streptomyces peucetius by the dnrR2 locus , 1995, Journal of bacteriology.

[2]  F. Lombó,et al.  The Mithramycin Gene Cluster of Streptomyces argillaceus Contains a Positive Regulatory Gene and Two Repeated DNA Sequences That Are Located at Both Ends of the Cluster , 1999, Journal of bacteriology.

[3]  C. Kao,et al.  A master regulator σB governs osmotic and oxidative response as well as differentiation via a network of sigma factors in Streptomyces coelicolor , 2005, Molecular microbiology.

[4]  C. Richard Hutchinson,et al.  The Streptomyces peucetius dpsY anddnrX Genes Govern Early and Late Steps of Daunorubicin and Doxorubicin Biosynthesis , 1998, Journal of bacteriology.

[5]  L. Vining,et al.  Nutritional control of actinorhodin production byStreptomyces coelicolor A3(2): suppressive effects of nitrogen and phosphate , 2004, Applied Microbiology and Biotechnology.

[6]  Seung-Hoon Kang,et al.  Doxorubicin Productivity Improvement by the Recombinant Streptomyces peucetius with High-Copy Regulatory Genes Cultured in the Optimized Media Composition , 2004 .

[7]  C R Hutchinson,et al.  Characterization of the Streptomyces peucetius ATCC 29050 genes encoding doxorubicin polyketide synthase. , 1994, Gene.

[8]  M. Smanski,et al.  Engineered Streptomyces platensis Strains That Overproduce Antibiotics Platensimycin and Platencin , 2009, Antimicrobial Agents and Chemotherapy.

[9]  C. Richard Hutchinson,et al.  The Streptomyces peucetius dpsC Gene Determines the Choice of Starter Unit in Biosynthesis of the Daunorubicin Polyketide , 1999, Journal of bacteriology.

[10]  Jae Kyung Sohng,et al.  Enhancement of doxorubicin production by expression of structural sugar biosynthesis and glycosyltransferase genes in Streptomyces peucetius. , 2009, Journal of bioscience and bioengineering.

[11]  J. Hahn,et al.  NdgR, an IclR-like regulator involved in amino-acid-dependent growth, quorum sensing, and antibiotic production in Streptomyces coelicolor , 2009, Applied Microbiology and Biotechnology.

[12]  S. U. Kim,et al.  The Streptomyces peucetius drrC gene encodes a UvrA-like protein involved in daunorubicin resistance and production , 1996, Journal of bacteriology.

[13]  C. Hutchinson,et al.  Purification and characterization of the DNA‐binding protein DnrI, a transcriptional factor of daunorubicin biosynthesis in Streptomyces peucetius , 1996, Molecular microbiology.

[14]  R. Prasad,et al.  Daunorubicin efflux in Streptomyces peucetius modulates biosynthesis by feedback regulation. , 2010, FEMS microbiology letters.

[15]  J. Sohng,et al.  Identification of the duplicated genes for S‐adenosyl‐l‐methionine synthetase (metK1‐sp and metK2‐sp) in Streptomyces peucetius var. caesius ATCC 27952 , 2010, Journal of applied microbiology.

[16]  Jae Kyung Sohng,et al.  Self-resistance mechanism in Streptomyces peucetius: overexpression of drrA, drrB and drrC for doxorubicin enhancement. , 2010, Microbiological research.

[17]  K. S. Lam,et al.  Stabilization Effect of Resin on the Production of Potent Proteasome Inhibitor NPI-0052 During Submerged Fermentation of Salinispora tropica , 2007, The Journal of Antibiotics.

[18]  J. Distler,et al.  The regulator of streptomycin gene expression, StrR, of Streptomyces griseus is a DNA binding activator protein with multiple recognition sites , 1995, Molecular microbiology.

[19]  N. Priestley,et al.  In vivo and in vitro bioconversion of epsilon-rhodomycinone glycoside to doxorubicin: functions of DauP, DauK, and DoxA , 1997, Journal of bacteriology.

[20]  K. Madduri,et al.  Functional characterization and transcriptional analysis of a gene cluster governing early and late steps in daunorubicin biosynthesis in Streptomyces peucetius , 1995, Journal of bacteriology.

[21]  D. Sherman,et al.  A gene cluster for macrolide antibiotic biosynthesis in Streptomyces venezuelae: architecture of metabolic diversity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[22]  C. Hutchinson,et al.  Cloning and characterization of the Streptomyces peucetius dnrQS genes encoding a daunosamine biosynthesis enzyme and a glycosyl transferase involved in daunorubicin biosynthesis , 1995, Journal of bacteriology.

[23]  K. Madduri,et al.  Cloning and characterization of the Streptomyces peucetius dnmZUV genes encoding three enzymes required for biosynthesis of the daunorubicin precursor thymidine diphospho-L-daunosamine , 1997, Journal of bacteriology.

[24]  C. Hutchinson,et al.  The DnrN protein of Streptomyces peucetius, a pseudo-response regulator, is a DNA-binding protein involved in the regulation of daunorubicin biosynthesis , 1996, Journal of bacteriology.

[25]  C. Kim,et al.  Improved production of teicoplanin using adsorbent resin in fermentations , 2003, Letters in applied microbiology.

[26]  P. Guilfoile,et al.  Expression and Characterization of DrrA and DrrB Proteins of Streptomyces peucetius in Escherichia coli : DrrA Is an ATP Binding Protein , 1997 .

[27]  J. Sohng,et al.  Precursor for biosynthesis of sugar moiety of doxorubicin depends on rhamnose biosynthetic pathway in Streptomyces peucetius ATCC 27952 , 2010, Applied Microbiology and Biotechnology.

[28]  D. Gewirtz,et al.  Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells. , 1994, Molecular pharmacology.

[29]  C. Kao,et al.  Reverse engineering of industrial pharmaceutical-producing actinomycete strains using DNA microarrays. , 2004, Metabolic engineering.

[30]  J. Sohng,et al.  Identification and functional characterization of an afsR homolog regulatory gene from Streptomyces venezuelae ATCC 15439. , 2009, Journal of microbiology and biotechnology.

[31]  C. Hutchinson,et al.  Enhanced antibiotic production by manipulation of the Streptomyces peucetius dnrH and dnmT genes involved in doxorubicin (adriamycin) biosynthesis , 1996, Journal of bacteriology.

[32]  Kang-mu Lee,et al.  Cloning and in vivo functional analysis by disruption of a gene encoding the γ-butyrolactone autoregulator receptor from Streptomyces natalensis , 2005, Archives of Microbiology.

[33]  Yinhua Lu,et al.  Characterization of a negative regulator AveI for avermectin biosynthesis in Streptomyces avermitilis NRRL8165 , 2008, Applied Microbiology and Biotechnology.

[34]  C. Hutchinson,et al.  Doxorubicin Overproduction in Streptomyces peucetius: Cloning and Characterization of the dnrU Ketoreductase anddnrV Genes and the doxA Cytochrome P-450 Hydroxylase Gene , 1999, Journal of bacteriology.

[35]  S. Siegel,et al.  Effect of adriamycin on DNA, RNA, and protein synthesis in cell-free systems and intact cells. , 1976, Cancer research.

[36]  J. Ward,et al.  The dnrM gene in Streptomyces peucetius contains a naturally occurring frameshift mutation that is suppressed by another locus outside of the daunorubicin-production gene cluster. , 1996, Microbiology.

[37]  M. Bibb,et al.  Regulation of secondary metabolism in streptomycetes. , 2005, Current opinion in microbiology.

[38]  Hao-Tian Jiang,et al.  Feedback regulation of doxorubicin biosynthesis in Streptomyces peucetius. , 2006, Research in microbiology.

[39]  Sang Yup Lee,et al.  Isolation and genetic manipulation of the antibiotic down-regulatory gene, wblA ortholog for doxorubicin-producing Streptomyces strain improvement , 2010, Applied Microbiology and Biotechnology.

[40]  A. Grein.  Antitumor anthracyclines produced by Streptomyces peucetius. , 1987, Advances in applied microbiology.

[41]  N. Priestley,et al.  Purification, Properties, and Characterization of Recombinant Streptomyces sp. Strain C5 DoxA, a Cytochrome P-450 Catalyzing Multiple Steps in Doxorubicin Biosynthesis , 1999, Journal of bacteriology.

[42]  J. Sohng,et al.  Identification and characterization of the afsR homologue regulatory gene from Streptomyces peucetius ATCC 27952. , 2005, Research in microbiology.

[43]  C. Hutchinson,et al.  A bacterial analog of the mdr gene of mammalian tumor cells is present in Streptomyces peucetius, the producer of daunorubicin and doxorubicin. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[44]  C. Hutchinson,et al.  Regulation of secondary metabolism in Streptomyces spp. and overproduction of daunorubicin in Streptomyces peucetius , 1992, Journal of bacteriology.

[45]  J. Sohng,et al.  Improvement in doxorubicin productivity by overexpression of regulatory genes in Streptomyces peucetius. , 2010, Research in microbiology.